CPC A61K 39/105 (2013.01) [A61K 39/0241 (2013.01); A61K 39/0275 (2013.01); A61K 39/12 (2013.01); C12N 7/00 (2013.01); A61K 35/74 (2013.01); A61K 39/295 (2013.01); A61K 39/39 (2013.01); A61K 2039/521 (2013.01); A61K 2039/522 (2013.01); A61K 2039/525 (2013.01); A61K 2039/542 (2013.01); A61K 2039/55 (2013.01); A61K 2039/552 (2013.01); A61K 2039/55566 (2013.01); A61K 2039/70 (2013.01); C12N 2750/10034 (2013.01); Y02A 50/30 (2018.01); Y10S 424/825 (2013.01)] | 5 Claims |
1. A pharmaceutical composition comprising antigens which consist essentially of:
i. killed Lawsonia intracellularis bacterium,
ii. killed Mycoplasma hyopneumoniae.
|